BLOG

Seven Corners Publishes Open Letter to Shareholders of Merrimack Pharmaceuticals Regarding Annual Me


Today Seven Corners Capital published an Open Letter to Shareholders of Merrimack Pharmaceuticals (ticker MACK) Regarding Proposals 4 & 5 Contained in MACK's Definitive Proxy Statement for its 2020 Annual Meeting (scheduled for May 28, 2020). THE LETTER ADVOCATES THAT MACK SHAREHOLDERS VOTE AGAINST PROPOSAL #4 AND FOR PROPOSAL #5 (I.E., IN EACH CASE AGAINST OUR BOARD’S RECOMMENDATIONS). For see a detailed discussion of each of these proposals, please see the PDF of our full letter, which has been posted in the Research Section of our website (see here).

Featured Posts
Recent Posts
Archive
  • LinkedIn Social Icon
  • RSS Social Icon
  • Twitter Social Icon
  • SA

Content © 2016-2020 Seven Corners Capital Management, LLC. All rights reserved.